CME Group Inc.
CME Group Inc. Annual Meeting Results: Director Election Proposals Fail, Amendment Passes
Summary
CME Group Inc. held its 2026 Annual Meeting of Shareholders on June 9, 2026. Proposals to eliminate the right of Class B-1, B-2, and B-3 shareholders to elect directors did not pass. However, an amendment to the certificate of incorporation passed, though it will not be filed due to the failure of other proposals. Class B-1 and B-2 directors were re-elected, while no Class B-3 director was elected due to lack of quorum.
Profitelligence Alerts
Get alerts for CME
Be first to know when CME Group Inc. files with the SEC.
Filing Categories
Advertisement
About CME Group Inc.
CME Group Inc. is a leading global marketplace for derivatives and futures trading. It provides a diverse range of products, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. CME Group's primary function is to facilitate risk management and price discovery, offering a centralized marketplace where traders can hedge against fluctuations in these various markets. Notable features include its electronic trading platform, CME Globex, enabling seamless access to its services worldwide, and its clearing services, ensuring the integrity and stability of the financial system. CME Group is crucial for market participants who require precise risk management tools, boasting significant influence in sectors like agriculture, energy, and global finance. As one of the largest futures and options exchanges, CME Group plays a pivotal role in the financial market by providing liquidity, transparency, and efficiency in trading activities.
Official SEC Documents
Advertisement